Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TXNL1 Induces Apoptosis in Cisplatin Resistant Human Gastric Cancer Cell Lines

(2015) Pan Ni et al.   CURRENT CANCER DRUG TARGETS

MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7

(2015) Xiaoying Zhou et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2

(2014) Mifang Yang et al.   Anti-Cancer Agents in Medicinal Chemistry

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

(2014) LINGJIE BAO et al.   Molecular Medicine Reports

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

(2014) Christopher J. Cheng et al.   NATURE

Regulation of microRNA function in somatic stem cell proliferation and differentiation

(2014) Archana Shenoy et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Drug Resistance in Cancer: An Overview

(2014) Genevieve Housman et al.   Cancers

Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma

(2013) Yong Guo et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN

(2013) Shou-mei Yang et al.   TOXICOLOGY

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11

(2013) Jessica Bockhorn et al.   Nature Communications

Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma

(2012) K. Sugimura et al.   CLINICAL CANCER RESEARCH

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance

(2012) Thea Eline Hetland et al.   HUMAN PATHOLOGY

Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

(2012) Dejuan Kong et al.   PLoS One

miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay

(2012) S. Djuranovic et al.   SCIENCE

MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation

(2011) Cheng-Chia Yu et al.   ORAL ONCOLOGY

Microrna let-7: an emerging next-generation cancer therapeutic

(2010) D. Barh et al.   Current Oncology

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis

(2010) Rui Liu et al.   EUROPEAN JOURNAL OF CANCER

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

(2010) Igor P. Pogribny et al.   INTERNATIONAL JOURNAL OF CANCER

Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell

(2009) Yan-Hong Zhang et al.   CANCER LETTERS

RNAi-mediated knockdown of AURKB and EGFR shows enhanced therapeutic efficacy in prostate tumor regression

(2009) M K Addepalli et al.   GENE THERAPY

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

(2009) Tetsuya Ueda et al.   LANCET ONCOLOGY

Aurora kinases

(2008) Xin Zhang   CURRENT BIOLOGY

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

(2008) O. Kovalchuk et al.   MOLECULAR CANCER THERAPEUTICS